IDEAS home Printed from https://ideas.repec.org/r/aea/apandp/v110y2020p269-73.html

Advance Market Commitments: Insights from Theory and Experience

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Chiappinelli, Olga & Giuffrida, Leonardo M. & Spagnolo, Giancarlo, 2023. "Public procurement as an innovation policy: Where do we stand?," ZEW Discussion Papers 23-002, ZEW - Leibniz Centre for European Economic Research.
  2. Kremer, Michael & Więcek, Witold & Ahuja, Amrita & Simoes Gomes Junior, Alexandre & Snyder, Christopher & Tabarrok, Alex & Tan, Brandon, 2021. "Could Vaccine Dose Stretching Reduce COVID-19 Deaths?," CEPR Discussion Papers 16324, C.E.P.R. Discussion Papers.
  3. Michael Kremer & Jonathan Levin & Christopher M. Snyder, 2022. "Designing Advance Market Commitments for New Vaccines," Management Science, INFORMS, vol. 68(7), pages 4786-4814, July.
  4. Chen, Simiao & Prettner, Klaus & Kuhn, Michael & Bloom, David E., 2021. "The economic burden of COVID-19 in the United States: Estimates and projections under an infection-based herd immunity approach," The Journal of the Economics of Ageing, Elsevier, vol. 20(C).
  5. Pierre Dubois, 2025. "Pharmaceutical Regulation and Incentives for Innovation in an International Perspective," Working Papers hal-05310888, HAL.
  6. Daniel P. Gross & Bhaven N. Sampat, 2022. "Crisis Innovation Policy from World War II to COVID-19," Entrepreneurship and Innovation Policy and the Economy, University of Chicago Press, vol. 1(1), pages 135-181.
  7. Dubois, Pierre & Moisson, Paul-Henri & Tirole, Jean, 2022. "The Economics of Transferable Patent Extensions," TSE Working Papers 22-1377, Toulouse School of Economics (TSE), revised Dec 2022.
  8. Giorgio Tripodi & Francesco Lamperti & Roberto Mavilia & Andrea Mina & Francesca Chiaromonte & Fabrizio Lillo, 2022. "Quantifying knowledge spillovers from advances in negative emissions technologies," LEM Papers Series 2022/17, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  9. Agarwal, Ruchir & Gaule, Patrick, 2022. "What drives innovation? Lessons from COVID-19 R&D," Journal of Health Economics, Elsevier, vol. 82(C).
  10. David E. Bloom & Michael Kuhn & Klaus Prettner, 2022. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
  11. Brian C. Albrecht & Shruti Rajagopalan, 2023. "Inframarginal externalities: COVID-19, vaccines, and universal mandates," Public Choice, Springer, vol. 195(1), pages 55-72, April.
  12. Jaspreet Pannu, 2020. "Inclusive Biomedical Innovation during the COVID‐19 Pandemic," Global Policy, London School of Economics and Political Science, vol. 11(5), pages 647-649, November.
  13. Sonia R. Bhalotra & Damian Clarke & Atheendar Venkataramani, 2025. "The Long Run Economic Effects of Medical Innovation and the Role of Opportunities," NBER Working Papers 34606, National Bureau of Economic Research, Inc.
  14. Gauri Kartini Shastry & Daniel L Tortorice, 2021. "Effective Foreign Aid: Evidence from Gavi’s Vaccine Program," Working Papers 2102, College of the Holy Cross, Department of Economics.
  15. repec:ags:cfcp15:344330 is not listed on IDEAS
  16. Auboin, Marc & Koopman, Robert & Xu, Ankai, 2021. "Trade and innovation policies: Coexistence and spillovers," Journal of Policy Modeling, Elsevier, vol. 43(4), pages 844-872.
  17. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).
  18. Jacob Moscona & Nathan Nunn & James A. Robinson, 2026. "Searching for Fish in Trees (緣木求魚)? Economic Development when Context Matters," Working Papers 2026-27, Becker Friedman Institute for Research In Economics.
  19. Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Canice Prendergast & Christopher M. Snyder & Ale, 2021. "Preparing for a Pandemic: Accelerating Vaccine Availability," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 331-335, May.
  20. Christopher Norio Avery & David McAdams, 2024. "The economics of epidemics: introduction to the special issue," Review of Economic Design, Springer;Society for Economic Design, vol. 28(4), pages 631-637, December.
  21. Christopher B. Barrett & Miguel I. Gόmez, 2025. "Fostering Healthy, Equitable, Resilient, and Sustainable Agri‐Food Value Chains," Agricultural Economics, International Association of Agricultural Economists, vol. 56(3), pages 390-400, May.
  22. Daniel P. Gross & Bhaven N. Sampat, 2021. "The Economics of Crisis Innovation Policy: A Historical Perspective," AEA Papers and Proceedings, American Economic Association, vol. 111, pages 346-350, May.
  23. Cozzi, Guido, 2022. "Shall we fear a Patent Waiver? Not for Covid-19 Vaccines," MPRA Paper 111990, University Library of Munich, Germany.
  24. Jonas Meckling & Joseph E. Aldy & Matthew J. Kotchen & Sanya Carley & Daniel C. Esty & Peter A. Raymond & Bella Tonkonogy & Charles Harper & Gillian Sawyer & Julia Sweatman, 2022. "Busting the myths around public investment in clean energy," Nature Energy, Nature, vol. 7(7), pages 563-565, July.
  25. Rachel Glennerster & Thomas Kelly & Claire T. McMahon & Christopher M. Snyder, 2024. "Quantifying the social value of a universal COVID-19 vaccine and incentivizing its development," Review of Economic Design, Springer;Society for Economic Design, vol. 28(4), pages 723-761, December.
  26. Achim Wambach, 2021. "Besseres Marktdesign im Gesundheitswesen," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 101(8), pages 590-593, August.
  27. Snyder, Christopher M. & Hoyt, Kendall & Gouglas, Dimitrios, 2023. "An optimal mechanism to fund the development of vaccines against emerging epidemics," Journal of Health Economics, Elsevier, vol. 91(C).
  28. Manheim, David & Foster, Derek, 2020. "Option-based guarantees to accelerate urgent, high risk vaccines: a new market-shaping approach," OSF Preprints swd4a, Center for Open Science.
  29. Chiappinelli, Olga & Giuffrida, Leonardo M. & Spagnolo, Giancarlo, 2025. "Public procurement as an innovation policy: Where do we stand?," International Journal of Industrial Organization, Elsevier, vol. 100(C).
  30. Gaurab Aryal & Federico Ciliberto & Leland E. Farmer & Ekaterina Khmelnitskaya, 2022. "Valuing Pharmaceutical Drug Innovations," Papers 2212.07384, arXiv.org, revised May 2026.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.